Activation of senescence in critically ill patients: mechanisms, consequences and therapeutic opportunities.

Authors:
Martín-Vicente P; López-Martínez C; Rioseras B; Albaiceta GM.

Journal:
Ann Intensive Care

Publication Year: 2024

DOI:
10.1186/s13613-023-01236-4

PMCID:
PMC10769968

PMID:
38180573

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ann Intensive Care

Abbreviation: Ann Intensive Care

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Critical Care Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Automated characterization of patient-ventilator interaction using surface electromyography.
Sauer J; Graßhoff J; Carbon NM and 3 more (2024) - Transparency Score: 4/6
Bedside personalized methods based on electrical impedance tomography or respiratory mechanics to s…
Pavlovsky B; Desprez C; Richard JC and 7 more (2024) - Transparency Score: 3/6
Bioimpedance-assessed muscle wasting and its relation to nutritional intake during the first week o…
Deana C; Gunst J; De Rosa S and 8 more (2024) - Transparency Score: 4/6
Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on …
Termorshuizen F; Dongelmans DA; Brinkman S and 6 more (2024) - Transparency Score: 3/6
Clinical and molecular epidemiological features of critically ill patients with invasive group A St…
Peetermans M; Matheeussen V; Moerman C and 22 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsNone. Competing interests None."

Evidence found in paper:

"Funding Supported by Centro de Investigación Biomédica en Red (CIBER)-Enfermedades Respiratorias (CB17/06/00021), Instituto de Salud Carlos III (PI20/01360, FEDER funds) and Gobierno del Principado de Asturias (FICYT, AYUD/2021/52014). CLM is supported by Ministerio de Universidades (FPU18/02965). PMV is supported by a Grant from Instituto de Salud Carlos III (FI21/00168). Instituto Universitario de Oncología del Principado de Asturias is supported by Fundación Liberbank."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025